
Esperion Therapeutics, Inc. (ESPR) Q3 2022 Earnings Call Transcript
Esperion Therapeutics, Inc. (NASDAQ:ESPR) Q3 2022 Earnings Conference Call November 1, 2022 8:00 AM ET Company Participants Tiffany Aldrich – Associate Director, Corporate Communications Sheldon Koenig – President & Chief Executive Officer JoAnne Foody – […]